Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HLA-A*11:01 is associated with levetiracetam-induced psychiatric adverse events.

PloS one - 1 Jan 2018

Yang Tae-Won, Moon Jangsup, Kim Tae-Joon, Jun Jin-Sun, Lim Jung-Ah, Lee Soon-Tae, Jung Keun-Hwa, Park Kyung-Il, Jung Ki-Young, Chu Kon, Lee Sang Kun

Abstract excerpt

Levetiracetam (LEV) is effective for focal and generalized epilepsy and is used worldwide because of its relatively few drug interactions and favorable tolerability. However, some psychiatric adverse events (PAEs) have been reported, resulting in drug withdrawal. The pathophysiology of LEV-induced PAE has not yet been elucidated. In this study, we investigated the relationship between PAEs and human leukocyte...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Alleles
Share to Epilepsy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epilepsy research and treatment

Share to Genotype

Share to HLA-A Antigens

Share to Pharmacological Effects and Toxicity Studies

Share to Republic of Korea

Source

Open in PubMed Open full text

Identifiers

PMID: 30020991
DOI: 10.1371/journal.pone.0200812
PMCID: PMC6051654

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HLA-A*11:01 is associated with levetiracetam-induced psychiatric adverse events.PMID 30020991Read ↗

Absence of HLA-B*1502 and HLA-A*3101 alleles in 9 Korean patients with antiepileptic drug-induced skin rash: a preliminary study.Semantic proximity Read ↗

Association of HLA Alleles with Antiepileptic Drug-Induced Mild Cutaneous Reactions: A Case-Control Study of a Northeast Han Chinese Population.Semantic proximity Read ↗

Hla-B alleles and lamotrigine-induced cutaneous adverse drug reactions in the Han Chinese population.Semantic proximity Read ↗

[Adverse effects of antiepileptic drugs].Semantic proximity Read ↗

HLA-associated adverse drug reactions - scoping review.Semantic proximity Read ↗

HLAs associated with perampanel-induced psychiatric adverse effects in a Korean population.Semantic proximity Read ↗

The HLA-A*2402/Cw*0102 haplotype is associated with lamotrigine-induced maculopapular eruption in the Korean population.Semantic proximity Read ↗

A pharmacogenomic assessment of psychiatric adverse drug reactions to levetiracetam.Semantic proximity Read ↗

Association Between HLA Genotype and Cutaneous Adverse Reactions to Antiepileptic Drugs Among Epilepsy Patients in Northwest ChinaSemantic proximity Read ↗

Clozapine rechallenge after excluding the high-risk clozapine-induced agranulocytosis genotype of HLA-DQB1 6672G>C.Semantic proximity Read ↗

Review or Updates on the clinical pharmacokinetics of levetiracetamSemantic proximity Read ↗

HLA-A*31:01 and lamotrigine-induced severe cutaneous adverse drug reactions in a Korean population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.